Yoshiga D, Nakamichi I, Yamashita Y, Yamamoto N, Yamauchi K, Nogami S, et al. Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ -. J Clin Exp Dent. 2014;6(1):e22-8.

 

doi:10.4317/jced.51213

http://dx.doi.org/doi:10.4317/jced.51213

 

References

1. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw --2009 update. J Oral Maxillofac Surg. 2009;35:119-30.                                                                     

                                                                     

2. Ruggiero SL, Carlson ER, Assael LA. Comprehensive review of bisphosphonate therapy: Implications for the oral and maxillofacial surgery patient. J Oral Maxillofac Surg. 2009;67:1.

http://dx.doi.org/10.1016/j.joms.2009.03.001

PMid:19371808                                                                   

                                                                     

3. Chapurlat R, Delmas PD. New treatments in osteoporosis. Rev Med Interne 25 Suppl. 2004;25:S573-579.

PMid:15841950                                                                                                                                                                              

                                                                                                                                                                                                                                                                                     

                                                                     

4. Marx RE. Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.

http://dx.doi.org/10.1016/S0278-2391(03)00720-1                                                        

PMid:12966493

                                                                     

5. Erkan M, Bilgi O, Mutluoglu M, Uzun G. Bisphosphonate-related osteonecrosis of the jaw in cancer patients and hyperbaric oxygen therapy. JOP. 2009;10:579-80.

PMid:19734644                                                                   

                                                                     

6. Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in japan. J Oral Maxillofac Surg. 2011;69:e364-71.

http://dx.doi.org/10.1016/j.joms.2011.03.051

PMid:21782307                                                                   

                                                                     

7. Mirzai R, Chang C, Greenspan A, Gershwin ME. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J Asthma.1999;36:77-95.

http://dx.doi.org/10.3109/02770909909065152

PMid:10077138                                                                   

                                                                     

8. Kuehn BM. Reports of adverse events from bone drugs prompt caution. JAMA. 2006;295:2833-6.

http://dx.doi.org/10.1001/jama.295.24.2833

PMid:16804139                                                                    

                                                                     

9. Diniz-Freitas M, L—pez-Cedrœn JL, Fern‡ndez-Sanrom‡n J, Garc’a-Garc’a A, Fern‡ndez-Feijoo J, Diz-Dios P. Med Oral Patol Oral Cir Bucal. 2012;17:751-8.

http://dx.doi.org/10.4317/medoral.18041

PMCid:PMC3482517                                                         

                                                                     

10. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415-23.

http://dx.doi.org/10.1016/j.joms.2006.10.061

PMid:17307586                                                                   

                                                                     

11. Marx RE. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:107-9.

http://dx.doi.org/10.1016/j.joms.2008.12.007

PMid:19371821                                                                   

                                                                     

12. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in australia. J Oral Maxillofac Surg. 2007;65:415-23.

http://dx.doi.org/10.1016/j.joms.2006.10.061

PMid:17307586                                                                   

                                                                     

13. Regev E, Lustmann J, Nashef R. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76.

http://dx.doi.org/10.1016/j.joms.2006.11.003

PMid:17307580                                                                   

                                                                     

14. Regev E, Lustmann J, Nashef R. Atraumatic teeth extraction in bisphosphonate-treated patients. J Oral Maxillofac Surg. 2008;66:1157-61.

http://dx.doi.org/10.1016/j.joms.2008.01.059

PMid:18486780                                                                    

                                                                     

15. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: A review of 34 cases and evaluation of risk. J Craniomaxillofac Surg. 2010;8:255-9.

http://dx.doi.org/10.1016/j.jcms.2009.06.005

PMid:19592261                                                                   

                                                                     

16. Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis of the jaw and bisphosphonates in cancer: A narrative review. Nat Rev Endocrinol. 2011;7:34-42.

http://dx.doi.org/10.1038/nrendo.2010.195

PMid:21079615                                                                   

                                                                     

17. Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum S, Pautke C. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg. 2012;40:303-9.

http://dx.doi.org/10.1016/j.jcms.2011.05.003

PMid:21676622                                                                   

                                                                     

18. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: A single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67:850-5.

http://dx.doi.org/10.1016/j.joms.2008.11.015

PMid:19304045                                                                   

                                                                     

19. Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mucke T, Mast G, Kohnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Sturzenbaum SR, Schieker M, Pautke C. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence--a multi-centre study. J Craniomaxillofac Surg. 2011;39:272-7.

http://dx.doi.org/10.1016/j.jcms.2010.05.009

PMid:20580566                                                                   

                                                                     

20. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc. 2006;137:1144-50.

http://dx.doi.org/10.14219/jada.archive.2006.0355

PMid:16873332                                                                   

                                                                     

21. Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: Can they be utilized as risk markers? Clin Oral Implants Res. 2011;22:100-5.

http://dx.doi.org/10.1111/j.1600-0501.2010.01965.x

PMid:20946206                                                                   

                                                                     

22. Worsfold M, Powell DE, Jones TJ, Davie MW. Assessment of urinary bone markers for monitoring treatment of osteoporosis. Clinical Chemistry. 2004;50:2263-70.

http://dx.doi.org/10.1373/clinchem.2004.037424

PMid:15472034                                                                   

                                                                     

23. Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C. Subtrochanteric fractures after long-term treatment with bisphosphonates: A european society on clinical and economic aspects of osteoporosis and osteoarthritis, and international osteoporosis foundation working group report. Osteoporos Int. 2011;22:373-90.

http://dx.doi.org/10.1007/s00198-010-1453-5

PMid:21085935 PMCid:PMC3020314                                                      

                                                                     

24. Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry. J Am Dent Assoc. 2009;140:61-6.

http://dx.doi.org/10.14219/jada.archive.2009.0019

PMid:19119168                                                                   

                                                                     

25. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum SR, Kolk A. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: First clinical results of a prospective pilot study. J Oral Maxillofac Surg. 2011;69:84-91.

http://dx.doi.org/10.1016/j.joms.2010.07.014

PMid:20971542